Cassava Sciences (SAVA) shared topline results from the Phase 3 REFOCUS-ALZ study of simufilam in mild-to-moderate AD. Topline data indicate that REFOCUS-ALZ did not meet each of the prespecified ...

An icon of a desk calendar. An icon of a circle with a diagonal line across. An icon of a block arrow pointing to the right. An icon of a paper envelope. An icon of the Facebook "f" mark.

The trial did not meet its primary endpoint of mean change in best corrected visual acuity from baseline to week 52. In wet AMD patients with minimally classic and occult lesions, participants ...

After a blockbuster first 12 months that saw us champion themes around Reinvention, Creation, Trailblazers and Disruption, this quarter we set our sights on the ICONS. Chronicling the bold and brave ...

TXOne Networks, a leading provider of Cyber-Physical Systems (CPS) security, recently unveiled Version 3.2 of its Stellar solution in an effort to advance its endpoint protection capabilities and ...